Quick Answer
Ocean Biomedical, Inc. reported Operating Income of -$3.80 million for fiscal year 2024.
Ocean Biomedical, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$3.80M | +62.8% |
| 2023 | -$10.21M | +36.6% |
| 2022 | -$16.12M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| March 31, 2025 | -$958.0K | -61.0% | -24.7% |
| September 30, 2024 | -$768.0K | +71.1% | -12.6% |
| June 30, 2024 | -$682.0K | +75.9% | -14.6% |
| March 31, 2024 | -$595.0K | +89.0% | +77.6% |
| September 30, 2023 | -$2.65M | +16.3% | +6.2% |
| June 30, 2023 | -$2.83M | +59.0% | +47.4% |
| March 31, 2023 | -$5.39M | -5.4% | -69.8% |
| September 30, 2022 | -$3.17M | -7327.8% | +54.0% |
- Ocean Biomedical, Inc. showed an increase of +62.8% in Operating Income compared to the prior fiscal year.
- Over the 2022–2024 period, Ocean Biomedical, Inc.’s operating income has grown by 76.4% (from -$16.12 million to -$3.80 million).
- The most recent figure is from Ocean Biomedical, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 8, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: